suPARnostic® eliminates doubt and supports your clinical decisions to discharge or admit patients based on prognostic evidence.

Implementing suPARnostic® in acute clinical care allows you to identify 34% * more non-acute patientsThis supports the decision to discharge patients,thereby reducing crowding and readmissions, leading to lower healthcare costs.

* Ref. 2016 EMJ Rasmussen et al.

Avoid unnecessary hospitalisation

suPAR is a prognostic biomarker that reflects the extent of activation of the immune system non-specific to any individual disease.

The suPAR level is directly linked to morbidity and mortality across diseases and can therefore be used to assess the mortality of patients in the emergency department.

Implementing suPARnostic leads to fewer non-acute patients being admittedand more patients being safely discharged.

How to interpret suPAR results

Documented by 700+ peer-reviewed publications

Here you can find a summary of the research done on suPAR within different disease areas.

Drawing of people disapearing

Improve patient outcomes and lower healthcare costs

Prognostic, data-based risk stratification increases the efficiency of the emergency department and improves patient outcomes.

Implementing suPARnostic® shortens the average patient length-of-stay by 6%* per patient and reduce crowding and hospital costs.*

* Schultz et al. Disease Markers, 2019, 10;1-8

The key challenge for the emergency department is to identify ill patients faster, make diagnoses faster, find the right specialist faster and initiate the right treatment faster.

– MD, Chief Physician Inger Søndergaard, Herlev Hospital, Copenhagen

NEW STUDY: early anakinra treatment for COVID-19 guided by suPAR saves lives

Get our whitepaper about the study results and read more about how an early start of anakinra treatment guided by suPAR provides 2.78 times better improvement of overall clinical status in moderate and severe COVID-19 pneumonia.

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates